Phibro Animal Health (PAHC) Gross Profit (2012 - 2026)

Phibro Animal Health's Gross Profit history runs 15 years deep, the most recent figure standing at $125.7 million for Q1 2026.

• In Q1 2026, Gross Profit rose 20.18% year-over-year to $125.7 million; the TTM figure through Mar 2026 stood at $488.1 million (up 29.45% YoY), while the FY2025 annual figure was $399.9 million, up 27.74% from the prior year.
• Gross Profit was $125.7 million for Q1 2026 at Phibro Animal Health, down from $132.7 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $132.7 million in Q4 2025 to a low of $67.7 million in Q3 2023.
• Historically, Gross Profit has averaged $90.6 million across 5 years, with a median of $79.6 million in 2024.
• The sharpest annual moves came in 2023 and 2025: Gross Profit fell 2.24% in 2023, then surged 43.46% in 2025.
• A 5-year view of Gross Profit shows it stood at $77.4 million in 2022, then grew by 1.59% to $78.6 million in 2023, then increased by 29.58% to $101.9 million in 2024, then surged by 30.22% to $132.7 million in 2025, then slipped by 5.26% to $125.7 million in 2026.
• The last three Gross Profit figures came in at $125.7 million (Q1 2026), $132.7 million (Q4 2025), and $119.8 million (Q3 2025), per Business Quant data.